Advertisement

Topics

Tandem Diabetes Care Announces Filing of Registration Statement for Proposed Follow-on Public Offering of Common Stock

16:25 EST 8 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced that it has filed a registration statement on Form S-1 ...

Other Sources for this Article

Tandem Diabetes Care, Inc.
Susan Morrison
858-366-6900 x7005
smorrison@tandemdiabetes.com

NEXT ARTICLE

More From BioPortfolio on "Tandem Diabetes Care Announces Filing of Registration Statement for Proposed Follow-on Public Offering of Common Stock"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...